Summary
The European Parliament has granted discharge to the Executive Director of the IMI 2 Joint Undertaking for the 2014 budget and approved its account closure, while noting areas for improved financial reporting. 10 14.09.2016
Other
budget
health
economy
administrative law
public administration
research and intellectual property
Key points
In force from 01/01/2014 Out of force from 31/12/2014
- The European Parliament grants discharge to the Executive Director and approves the closure of accounts for the 2014 financial year.
- The Court of Auditors confirmed that the annual accounts fairly represent the financial position and that transactions were legal and regular.
- Concerns were raised regarding insufficient documentation for controls performed before project costs are paid.
- The Parliament called for a clearer separation of data between different research funding programs in future reports.
Documents (PDFs)
REPORT on discharge in respect of the implementation of the budget of the Innovative Medicines Initiative 2 Joint Undertaking (formerly the Joint Undertaking for the implementation of the Joint Technology Initiative on Innovative Medicines) for the financial year 2014
Discharge 2014 : Innovative Medicines Initiative 2 Joint Undertaking
These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.